Similarly, the HAPLN1 level in the plasma of RA patients (n=61) was higher than that of OA patients (n=20) and healthy control subjects (HC, n=12) (Figure 1B and Supplementary Table S2 for participants’ details). Here, HAPLN1 is linked to rheumatoid arthritis.